Cargando…
Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant glioma
Glioblastoma is an aggressive primary brain cancer. Given our interest in novel immunotherapies, we have recently shown that inhibiting CTLA-4, PD-L1 and IDO results in a dramatic survival advantage in mice with brain tumors. Our preclinical study supports the rapid translation of this approach into...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091585/ https://www.ncbi.nlm.nih.gov/pubmed/25057450 http://dx.doi.org/10.4161/onci.28927 |